Drug Therapy and Development of Novel Drugs

According to Food and Drug Administration (FDA), Conserved domain Database(CDD), there a few characterized therapies for liver cancer like Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy. From researchers note it is reported that targeted therapy is a way better approach than standard chemotherapy. Sorafenib is one of the best Targeted drug that controls the growth of proteins stimulating cancer cells. Regorafenib is one of the additional dug in blocking the proteins helping the growth of tumour cells. Liver cancer Organoids are used in developing new drugs in treatment of liver cancer.

  • Tyrosine Kinase Inhibitor
  • Targeted Therapy
  • Phases of Development
  • Microtubule Inhibitor

Related Conference of Drug Therapy and Development of Novel Drugs

October 29-30, 2018

4th World Congress on Digestive & Metabolic Diseases

| San Francisco, California, USA
November 07-08, 2018

World Summit on Liver Cirrhosis and Hepatitis

Singapore
December 17-18, 2018

3rd World Liver Congress

Abu Dhabi, UAE
January 30-31, 2019

16th World Congress on Gastroenterology & Therapeutics

Bangkok, Thailand
March 04-05, 2019

20th World Congress on Gastroenterology

Berlin, Germany
June 17-18, 2019

World Liver Conference 2019

Columbus, Ohio, U.S.A
July 08-09, 2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia

Drug Therapy and Development of Novel Drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in